Status:
COMPLETED
Response to Clenbuterol in Humans
Lead Sponsor:
University of Copenhagen
Conditions:
Healthy
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Due to the long half-life (\~36 hr) of clenbuterol, detection methods such as dried blood spots (DBS) are a potentially suitable method to easily and non-invasively detect doping misuse of this compou...
Eligibility Criteria
Inclusion
- Healthy
- Male
- 18-40 years of age
- No known contraindications for anabolic drugs (e.g. cancer)
Exclusion
- Abnormal ECG
- Steroid abuse
- Ongoing use of prescription medication
- heavy resistance training more than 2 times weekly
- Disease deemed by the MD to infer a risk to participate in the trial
Key Trial Info
Start Date :
March 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03860870
Start Date
March 11 2019
End Date
December 21 2022
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
August Krogh Building
Copenhagen, Denmark